People · Operator
Named in public records as an officer, director or promoter · active 2009–2023 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MediBeacon Inc. | — | Other Health Care | Series B | $87.5M | $135.6M | 2015 |
| Palyon Medical Corp | — | Biotechnology | Series B | $45.0M | $952.5M | 2009 |
| Genovel Orthopedics, Inc. | — | Biotechnology | Seed | $1.0M | $44.4M | 2014 |
David Present at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Present on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Cherine Plumaker | 3 | 3 |
| Michael Liang | 1 | 9 |
| Steven Miller | 1 | 6 |
| Daniel Omstead | 1 | 4 |
| Glen Kashuba | 1 | 3 |
| Steve Hanley | 1 | 3 |
| Aidan King | 1 | 3 |
| Richard A. Lytle | 1 | 2 |
| Steven Hanley | 1 | 2 |
| Gregory David | 1 | 1 |
| Richard B. Dorshow | 1 | 1 |
| Charles B. Bolten | 1 | 1 |
| John A. Friel | 1 | 1 |
| Terence B. Stern | 1 | 1 |
| Richard Dorshow | 1 | 1 |
| Terence Stern | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.